0001179110-18-002674.txt : 20180223
0001179110-18-002674.hdr.sgml : 20180223
20180223114551
ACCESSION NUMBER: 0001179110-18-002674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180221
FILED AS OF DATE: 20180223
DATE AS OF CHANGE: 20180223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnston David Brannon
CENTRAL INDEX KEY: 0001486519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 18635317
MAIL ADDRESS:
STREET 1: C/O IMMUNOGEN, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-21
0
0000855654
IMMUNOGEN INC
IMGN
0001486519
Johnston David Brannon
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Common Stock
2018-02-21
4
S
0
21060
10.87
D
180690
D
Weighted average price of shares sold.
The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.
/s/ Craig Barrows, attorney in fact
2018-02-23